Avid Bioservices, Inc.

Avid Bioservices, Inc. operates as a biopharmaceutical company. The Company focuses on development and manufacturing of biopharmaceutical products derived from mammalian cell culture. Avid Bioservices provides clinical and commercial manufacturing services for biotechnology industries. Avid Bioservices serves customers in the United States.

Bank Name Avid Bioservices, Inc.
Stock Exchange NASDAQ
Symbol CDMO
Sector Healthcare
Industry Major Pharmaceuticals
Country United States
World Region America
CEO Mr. Paul J. Lytle
Employees 319
Website www.avidbio.com
Registered Year 2018